Transforming clinical microbiology with bacterial genome sequencing

X Didelot, R Bowden, DJ Wilson, TEA Peto… - Nature Reviews …, 2012 - nature.com
Whole-genome sequencing of bacteria has recently emerged as a cost-effective and
convenient approach for addressing many microbiological questions. Here, we review the …

Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015

Y Zhang, WW Yew - … Journal of Tuberculosis and Lung Disease, 2015 - ingentaconnect.com
Drug-resistant tuberculosis (DR-TB), including multi-and extensively drug-resistant TB, is
posing a significant challenge to effective treatment and TB control worldwide. New progress …

Highly multiplexed rapid DNA detection with single-nucleotide specificity via convective PCR in a portable device

D Khodakov, J Li, JX Zhang, DY Zhang - Nature Biomedical …, 2021 - nature.com
Assays for the molecular detection of nucleic acids are typically constrained by the level of
multiplexing (this is the case for the quantitative polymerase chain reaction (qPCR) and for …

Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A …

E Avalos, D Catanzaro, A Catanzaro, T Ganiats… - PloS one, 2015 - journals.plos.org
Background The detection of mutations in the gyrA and gyrB genes in the Mycobacterium
tuberculosis genome that have been demonstrated to confer phenotypic resistance to …

De novo emergence of genetically resistant mutants of Mycobacterium tuberculosis from the persistence phase cells formed against antituberculosis drugs in vitro

J Sebastian, S Swaminath, RR Nair… - Antimicrobial agents …, 2017 - journals.asm.org
Bacterial persisters are a subpopulation of cells that can tolerate lethal concentrations of
antibiotics. However, the possibility of the emergence of genetically resistant mutants from …

Drug resistance mechanisms and novel drug targets for tuberculosis therapy

MM Islam, HMA Hameed, J Mugweru… - Journal of genetics and …, 2017 - Elsevier
Drug-resistant tuberculosis (TB) poses a significant challenge to the successful treatment
and control of TB worldwide. Resistance to anti-TB drugs has existed since the beginning of …

Specific gyrA gene mutations predict poor treatment outcome in MDR-TB

L Rigouts, N Coeck, M Gumusboga… - Journal of …, 2016 - academic.oup.com
Objectives Mutations in the gyrase genes cause fluoroquinolone resistance in
Mycobacterium tuberculosis. However, the predictive value of these markers for clinical …

Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates

JY Chien, WY Chiu, ST Chien, CJ Chiang… - Antimicrobial agents …, 2016 - journals.asm.org
In order to correlate the mutations inside the entire gyrA and gyrB genes with the level of
resistance to ofloxacin (OFX) and moxifloxacin (MFX) in isolates of multidrug-resistant …

Whole Genome Sequencing of Mycobacterium tuberculosis Clinical Isolates From India Reveals Genetic Heterogeneity and Region-Specific Variations That Might …

J Advani, R Verma, O Chatterjee, PK Pachouri… - Frontiers in …, 2019 - frontiersin.org
Whole genome sequencing (WGS) of Mycobacterium tuberculosis has been constructive in
understanding its evolution, genetic diversity and the mechanisms involved in drug …

Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China

Z Zhang, J Lu, Y Wang, Y Pang… - Antimicrobial agents and …, 2014 - journals.asm.org
China is one of the countries with the highest burdens of multidrug-resistant (MDR) and
fluoroquinolone (FQ)-resistant tuberculosis (TB) globally. Nevertheless, knowledge about …